A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis
Individuals with Dupuytren’s disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue spec...
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Journal article |
| Baskı/Yayın Bilgisi: |
Cell Press
2017
|
| _version_ | 1826269309870014464 |
|---|---|
| author | Ng, M Thakkar, D Southam, L Werker, P Ophoff, R Becker, K Nothnagel, M Franke, A Nurnberg, P Espirito-Santo, A Izadi, D Hennies, H Nanchahal, J Zeggini, E Furniss, D |
| author_facet | Ng, M Thakkar, D Southam, L Werker, P Ophoff, R Becker, K Nothnagel, M Franke, A Nurnberg, P Espirito-Santo, A Izadi, D Hennies, H Nanchahal, J Zeggini, E Furniss, D |
| author_sort | Ng, M |
| collection | OXFORD |
| description | Individuals with Dupuytren’s disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue specific fibroses. DD affects between 5 and 25% of people of European descent, and is the most common inherited disease of connective tissue. We undertook the largest GWAS to date in individuals with a surgically validated diagnosis of DD from the UK, with replication in British, Dutch and German individuals. We validated association at all nine previously described signals, and discovered 17 additional variants with P≤5x10-8. As a proof of principle, we demonstrated correlation of the high-risk genotype at the statistically most strongly associated variant with decreased secretion of the soluble WNT-antagonist SFRP4, in surgical specimen derived DD myofibroblasts. These results highlight important pathways involved in the pathogenesis of fibrosis, including WNT signaling, extracellular matrix modulation, and inflammation. In addition, many associated loci contain genes that are hitherto unrecognized as playing a role in fibrosis, opening up new avenues of research that may lead to novel treatments for DD and fibrosis more generally. DD represents an ideal human model disease for fibrosis research. |
| first_indexed | 2024-03-06T21:23:04Z |
| format | Journal article |
| id | oxford-uuid:4225ba99-9d15-4007-a2d1-bf5a88e5840c |
| institution | University of Oxford |
| last_indexed | 2024-03-06T21:23:04Z |
| publishDate | 2017 |
| publisher | Cell Press |
| record_format | dspace |
| spelling | oxford-uuid:4225ba99-9d15-4007-a2d1-bf5a88e5840c2022-03-26T14:47:45ZA genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4225ba99-9d15-4007-a2d1-bf5a88e5840cSymplectic Elements at OxfordCell Press2017Ng, MThakkar, DSoutham, LWerker, POphoff, RBecker, KNothnagel, MFranke, ANurnberg, PEspirito-Santo, AIzadi, DHennies, HNanchahal, JZeggini, EFurniss, DIndividuals with Dupuytren’s disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue specific fibroses. DD affects between 5 and 25% of people of European descent, and is the most common inherited disease of connective tissue. We undertook the largest GWAS to date in individuals with a surgically validated diagnosis of DD from the UK, with replication in British, Dutch and German individuals. We validated association at all nine previously described signals, and discovered 17 additional variants with P≤5x10-8. As a proof of principle, we demonstrated correlation of the high-risk genotype at the statistically most strongly associated variant with decreased secretion of the soluble WNT-antagonist SFRP4, in surgical specimen derived DD myofibroblasts. These results highlight important pathways involved in the pathogenesis of fibrosis, including WNT signaling, extracellular matrix modulation, and inflammation. In addition, many associated loci contain genes that are hitherto unrecognized as playing a role in fibrosis, opening up new avenues of research that may lead to novel treatments for DD and fibrosis more generally. DD represents an ideal human model disease for fibrosis research. |
| spellingShingle | Ng, M Thakkar, D Southam, L Werker, P Ophoff, R Becker, K Nothnagel, M Franke, A Nurnberg, P Espirito-Santo, A Izadi, D Hennies, H Nanchahal, J Zeggini, E Furniss, D A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title | A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title_full | A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title_fullStr | A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title_full_unstemmed | A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title_short | A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis |
| title_sort | genome wide association study of dupuytren s disease reveals 17 additional variants implicated in fibrosis |
| work_keys_str_mv | AT ngm agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT thakkard agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT southaml agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT werkerp agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT ophoffr agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT beckerk agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nothnagelm agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT frankea agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nurnbergp agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT espiritosantoa agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT izadid agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT henniesh agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nanchahalj agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT zegginie agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT furnissd agenomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT ngm genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT thakkard genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT southaml genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT werkerp genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT ophoffr genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT beckerk genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nothnagelm genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT frankea genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nurnbergp genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT espiritosantoa genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT izadid genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT henniesh genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT nanchahalj genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT zegginie genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis AT furnissd genomewideassociationstudyofdupuytrensdiseasereveals17additionalvariantsimplicatedinfibrosis |